Southcoast Center for Cancer Care, Fairhaven, MA
Patrick John Skeffington , Laura Haynes , Donna Raymond , Heather McCarthy
Background: Use of oral chemotherapy has increased dramatically over the past few years. Patient often are required to obtain their oral chemotherapy from a third party specialty pharmacy while continuing to receive their other medications from other pharmacies. Many community pharmacists lack knowledge about oral chemotherapy, safe practices, or effective counseling of these medications. Objective: To assess patient perception and satisfaction of a pharmacist 1 on 1 appointment when starting oral chemotherapy. Methods: A program was designed at SCCC whereby all patients starting oral chemotherapy are scheduled for an appointment with a clinical oncology pharmacist to update medication lists, evaluate adherence, and conduct a "brown bag" visit where patients are allowed to voice concerns and ask questions. After each appointment patients were asked to fill out a short survey, The Patient Satisfaction with Pharmacist Services Questionnaire (PSPSQ 2.0). Results: PSPSQ 2.0 uses a Likert scale ranging from 1 to 4. From October 2016 to June 2019, 174 patients had appointments and 55 returned their surveys yielding a 30% response rate. Average scores hovered around 1 (strongly agree) for each question except question 11 (the only negatively worded question). Question 11 averaged 3.1; Disagree. Conclusions: Patients who were seen by an oncology clinical pharmacist to evaluate adherence, participate in a "brown bag" clinic and open discussion, found the appointment worthy of their time.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2022 ASCO Annual Meeting
First Author: Analia Nguyen
2021 ASCO Quality Care Symposium
First Author: Robert Harrison Hester
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Kohei Shitara
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Hendrik-Tobias Arkenau